Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026)

Capricor Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 505.27% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 505.27% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 423.0% from the prior year.
• Other Non-Current Assets climbed to $1.5 million in Q1 2026 per CAPR's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.5 million in Q1 2026 and bottomed at $221700.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $268172.0 (2022), against an average of $426490.4.
• Across the five-year window, Other Non-Current Assets fell 17.33% in 2024 and surged 505.27% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then slipped by 17.33% to $221700.0 in 2024, then jumped by 423.0% to $1.2 million in 2025, then soared by 32.27% to $1.5 million in 2026.
• Per Business Quant, the three latest CAPR Other Non-Current Assets figures stand at $1.5 million (Q1 2026), $1.2 million (Q4 2025), and $488738.0 (Q3 2025).